Andrew Jones
Dr. Jones leads a lab at Miami University-Ohio focusing on the biosynthesis of various psychedelics and psychedelic-inspired compounds. He has mentored over 50 research trainees and published over 35 peer reviewed papers.
Miami University
Wednesday
May 07
Synthesizing Psychedelics: Unpacking the Options for Psychedelics Production
3:30 PM
-
4:15 PM
In this session we will explore the many methods of producing psychedelic and psychedelic-inspired compounds for clinical applications. The discussion will center around the pros and cons of a synthetic biology-based approach as compared with chemical synthetic and natural product extraction-based approaches. We will discuss topics such as environmental sustainability, scalability, technology transfer, and cost, as well as how future disrupting technologies could impact this emerging field.